Agendia has made three appointments to its executive team. David Macdonald has been named chief operating officer, Mark Willig is executive vice president of North American sales, and Doug Bradley has been appointed vice president of global marketing.
Macdonald has been involved in commercializing clinical diagnostics and lab services tools at Nanogen, AltheaDx, Behring Diagnostics, and the Nichols Institute. Willig was general manager and chief commercial officer at Exiqon, vice president of global sales for Thermo Fisher's pathology business, and worked at Myriad Genetics and Abbott Diagnostics. Bradley has worked at Coherent Medical, Allergan, SenoRx, and at Vertos Medical.
John Krayacich has joined Exact Sciences as senior vice president of sales and marketing.
Krayacich was most recently president and chief executive officer of two startup biotechnology companies: Ambrose Pharmaceuticals and Marinus Pharmaceuticals. Prior to that, Krayacich held executive positions at Novartis, Pfizer Neurosciences, and Parke-Davis.
Jay Moyes has been appointed to the board of directors at Integrated Diagnostics. Moyes was previously chief financial officer of Myriad Genetics and chief financial officer of XDx. He is currently director and chair of the audit committees of both Osiris Therapeutics and BioCardia.